Enzo Biochem Reports Fiscal Third Quarter and Nine Months Operating Results


NEW YORK–(BUSINESS WIRE)–Enzo Biochem, Inc. (NYSE:ENZ), an integrated life sciences company focused on commercializing innovative diagnostic and therapeutics products, today reported results for the fiscal quarter and nine months ended April 30, 2019. The Company updated the market on the progress of its short-term growth and profitability initiatives designed to unlock value. Financial Results Third quarter net income was $22.3 million, or $0.47 per share including $28.9 million in net legal….